Barriers to novel therapeutics in amyotrophic lateral sclerosis

ISSN： 1758-2024

Source： Neurodegenerative Disease Management, Vol.3, Iss.6, 2013-12, pp. : 525-537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Amyotrophic Lateral Sclerosis.

By Mitchell J.D.

Brain, Vol. 123, Iss. 11, 2000-11 ,pp. : 2361-2363

Oxford University Press

Access to resources Recommend Favorite

Mitochondria in Sporadic Amyotrophic Lateral Sclerosis

By Swerdlow R.H. Parks J.K. Cassarino D.S. Trimmer P.A. Miller S.W. Maguire D.J. Sheehan J.P. Maguire R.S. Pattee G. Juel V.C. Phillips L.H. Tuttle J.B. Bennett J.P. Davis R.E. Parker W.D.

Experimental Neurology, Vol. 153, Iss. 1, 1998-09 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite

Quantitative electroencephalography in amyotrophic lateral sclerosis

By Mai R. Facchetti D. Micheli A. Poloni M.

Electroencephalography and Clinical Neurophysiology, Vol. 106, Iss. 4, 1998-04 ,pp. : 383-386

Elsevier

Access to resources Recommend Favorite

Amyotrophic lateral sclerosis: a multifactorial disease

By Eisen A.

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 3-3

Elsevier

Access to resources Recommend Favorite

Energy Intake and Amyotrophic Lateral Sclerosis

NeuroMolecular Medicine, Vol. 9, Iss. 1, 2007-02 ,pp. : 17-20

Humana Press, Inc

Access to resources Recommend Favorite